Axogen, Inc. Common Stock
$44.23
-$1.05 (-2.33%)
$44.16Day Range$45.66
Key Statistics
Market Cap
$2.66B
Shares Outstanding
58.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 17, 1986
Round Lot
100
Locale
US
Trading Data
Day Open
$44.94
Day High
$45.66
Day Low
$44.16
Volume
1.12M
VWAP
$44.64
Prev Close
$45.28
Transactions
--
Acc. Volume
--
About Axogen, Inc. Common Stock
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSSIC 3845622 employees13631 PROGRESS BLVD., ALACHUA, FL, 32615(386) 462-6817IPO Dec 17, 1986US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000805928
- Composite FIGI
- BBG000BN46R9
- Share Class FIGI
- BBG001S5SRD1
- Ticker Root
- AXGN
- SIC Code
- 3845
About Axogen, Inc. Common Stock (AXGN) Stock
Axogen, Inc. Common Stock (AXGN) closed the 2026-09-18 session at $44.23, down 2.33% versus the previous close (-1.05). The stock opened at $44.94 and traded between $44.16 and $45.66 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $44.64.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Axogen, Inc. Common Stock has a market capitalization of $2.66 billion. The company operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry classification. AXGN is listed on the XNAS exchange. The company employs approximately 622 people. Axogen, Inc. Common Stock is headquartered in ALACHUA, FL. The recorded listing date is 1986-12-17.
On this page you can find market AXGN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.